Using Virus-Like Particles to Protect Mice from Prostate Cancer
Author Information
Author(s): Mathilda Eriksson, Kalle Andreasson, Joachim Weidmann, Kajsa Lundberg, Karin Tegerstedt, Tina Dalianis, Torbjörn Ramqvist
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
Can murine polyomavirus virus-like particles carrying human prostate specific antigen protect mice from tumor outgrowth?
Conclusion
Immunization with PSA-MPyVLPs loaded onto dendritic cells and co-injected with CpG induces an efficient immune response against PSA, protecting mice from tumor outgrowth.
Supporting Evidence
- Immunization with PSA-MPyVLPs alone resulted in a 50% tumor take compared to 79% in non-immunized mice.
- Co-injection of PSA-MPyVLPs and CpG resulted in a protective effect with a 46% tumor take.
- Loading of PSA-MPyVLPs onto dendritic cells and co-injecting with CpG reduced the tumor take to 15%.
Takeaway
Researchers created a vaccine using virus-like particles to help mice fight prostate cancer, and it worked better when combined with special immune cells.
Methodology
BALB/c mice were immunized with PSA-MPyVLPs, either alone or loaded onto dendritic cells, and co-injected with CpG adjuvant, followed by tumor cell challenge.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Female BALB/c mice, aged 6–10 weeks.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website